BTAI · BioXcel Therapeutics, Inc.
$0.07
-0.04 (-37.11%)
At close · Sep 4
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have identified conditions and events that raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$2.31M
Shares
31.31M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-01 | 2026-08-31 | |
| 8-K | 2026-08-28 | 2026-08-27 | |
| 8-K | 2026-08-25 | 2026-08-24 | |
| 8-K | 2026-08-24 | 2026-08-21 | |
| 10-Q | 2026-08-13 | 2026-06-30 | |
| 8-K | 2026-08-11 | 2026-08-10 | |
| 8-K | 2026-08-03 | 2026-07-31 | |
| 8-K | 2026-07-06 | — | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-05-15 | — | |
| 8-K | 2026-04-17 | 2026-04-15 | |
| 8-K | 2026-04-01 | — | |
| 8-K | 2026-03-27 | — | |
| 10-K | 2026-03-27 | 2025-12-31 | |
| 8-K | 2026-03-11 | 2026-03-10 | |
| 8-K | 2026-02-12 | — | |
| 8-K | 2026-02-06 | 2026-02-04 | |
| 8-K | 2026-01-20 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-15 | 2025-12-12 | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| DEF 14A | 2025-11-12 | 2025-12-12 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-10-30 | — | |
| 8-K | 2025-10-14 | — | |
| 8-K | 2025-09-15 | — | |
| 8-K | 2025-09-10 | — | |
| 8-K | 2025-08-27 | — | |
| Investor Event Transcript | 2025-08-27 | 2025-09-30 | |
| 8-K | 2025-08-18 | — | |
| 8-K | 2025-08-18 | — | |
| 8-K | 2025-08-15 | 2025-08-14 | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-11 | — | |
| 8-K | 2025-08-11 | — | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-08-01 | — | |
| 8-K | 2025-07-21 | — | |
| 8-K | 2025-07-15 | — | |
| 8-K | 2025-05-27 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-12 | — | |
| 8-K | 2025-04-03 | — | |
| 10-K | 2025-03-28 | 2024-12-31 | |
| 8-K | 2025-03-27 | — | |
| 8-K | 2025-03-21 | 2025-03-20 | |
| 8-K | 2025-03-21 | 2025-03-20 | |
| 8-K | 2025-03-04 | 2025-03-03 |
Showing 1–50 of 169 filings
Key facts
CIK
1720893
CUSIP
09075P204
13F (30d)
38 filings
38 filers
Visit website
Investor relations